These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 9360647)

  • 41. Re-evaluation of adequate dose in Japanese peritoneal dialysis patients.
    Yamashita AC; Ishizaki M; Nakamoto M; Kawanishi H; Hamada H
    Adv Perit Dial; 2003; 19():103-5. PubMed ID: 14763043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body surface area, adequacy, and technique failure in chronic peritoneal dialysis.
    Barone RJ; Cámpora MI; Gimenez NS; Ramirez L; Santopietro M; Panese SA
    Adv Perit Dial; 2010; 26():105-9. PubMed ID: 21348391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAPD with a night-exchange device is the only true CAPD?
    Pagé DE
    Adv Perit Dial; 1998; 14():60-3. PubMed ID: 10649692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous tidal peritoneal dialysis (CTPD) prescription and adequacy targets.
    Amici G; Virga G; Da Rin G; Bocci C; Calconi G
    Adv Perit Dial; 1998; 14():64-7. PubMed ID: 10649693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discrepancy between weekly KT/V and weekly creatinine clearance in patients on CAPD.
    Chen HH; Shetty A; Afthentopoulos IE; Oreopoulos DG
    Adv Perit Dial; 1995; 11():83-7. PubMed ID: 8534745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.
    Vonesh EF; Story KO; O'Neill WT
    Perit Dial Int; 1999; 19(6):556-71. PubMed ID: 10641777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients on continuous ambulatory peritoneal dialysis.
    Yu XF; Zhou YF; Feng L; Zhang DL; Liu WH
    Chin Med J (Engl); 2009 Dec; 122(24):2977-80. PubMed ID: 20137485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients.
    Mak SK; Wong PN; Lo KY; Tong GM; Fung LH; Wong AK
    Am J Kidney Dis; 2000 Jul; 36(1):105-14. PubMed ID: 10873879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calculation of Kt/V and creatinine [correction of creatine] clearance in APD.
    Viglino G; Neri L; Gandolfo C; Cavalli PL
    Adv Perit Dial; 1998; 14():68-71. PubMed ID: 10649694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sources of variation in estimates of lean body mass by creatinine kinetics and by methods based on body water or body mass index in patients on continuous peritoneal dialysis.
    Tzamaloukas AH; Murata GH; Piraino B; Raj DS; VanderJagt DJ; Bernardini J; Servilla KS; Sun Y; Glew RH; Oreopoulos DG
    J Ren Nutr; 2010 Mar; 20(2):91-100. PubMed ID: 19853476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role still exists for cycler therapy in anuric patients with a low-transport membrane.
    Pagé DE; Cheung V
    Adv Perit Dial; 2001; 17():114-6. PubMed ID: 11510256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.
    Vonesh EF; Burkart J; McMurray SD; Williams PF
    Perit Dial Int; 1996; 16(5):471-81. PubMed ID: 8914177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender differences in normalized clearances in CAPD: role of body size and normalizing parameters.
    Tzamaloukas AH; Murata GH; Bernardini J; Malhotra D; Rao P; Piraino B; Oreopoulos DG
    Perit Dial Int; 1999; 19(2):165-9. PubMed ID: 10357189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peritoneal dialysis survival in relation to patient body size and peritoneal transport characteristics.
    Prowant BF; Moore HL; Satalowich R; Twardowski ZJ
    Nephrol Nurs J; 2010; 37(6):641-6; quiz 647. PubMed ID: 21290918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum albumin in continuous peritoneal dialysis: absence of universal predictors.
    Tzamaloukas AH; Balaskas EV; Voudiklari S; Malhotra D; Nicolopoulou N; Dimitriadis A; Dombros NV; Murata GH
    Adv Perit Dial; 1997; 13():146-9. PubMed ID: 9360670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum cystatin C: a surrogate marker for the characteristics of peritoneal membrane in dialysis patients.
    Al-Wakeel JS; Hammad D; Memon NA; Tarif N; Shah I; Chaudhary A
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):227-31. PubMed ID: 19237809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of peritoneal solute transport parameters in diabetics treated with continuous ambulatory peritoneal dialysis].
    Baczyński D; Marciniak M; Olszowska A; Waniewski J; Weryński A; Wańkowicz Z
    Pol Merkur Lekarski; 1998 Nov; 5(29):274-6. PubMed ID: 10101499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.